Actuate Therapeutics, Inc.
ACTU- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001652935
In the last 90 days, Actuate Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 62 institutions reported holding it in 13F filings for Q2 2026, worth $20.6M in total; no superinvestor holds it.
Holders of 5% or more of ACTU
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Actuate Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| BIOS Fund I, LP | 13D/A | 49.80%10.3M shares | −2.60 ppfrom 52.40% | Aug 19, 20243 filings | Jun 30, 2025 | SEC |
| Hexstone Capital LLC | 13G | 7.70%4.23M shares | New | Oct 30, 20261 filing | Oct 30, 2026 | SEC |
| Voss Capital, LLC | 13G/A | 7.70%1.81M shares | +2.40 ppfrom 5.30% | Dec 17, 20252 filings | Apr 22, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
6 Schedule 13D and 13G filings on Actuate Therapeutics, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Oct 30, 20264:05 PM ET | Hexstone Capital LLCand 1 other | 13G | 7.70%4.23M shares | New | Oct 27, 2026 | SEC |
| Apr 22, 20263:24 PM ET | Voss Capital, LLCand 4 others | 13G/A | 7.70%1.81M shares | +2.40 ppfrom 5.30% | Mar 31, 2026 | SEC |
| Dec 17, 202512:25 PM ET | Voss Capital, LLCand 4 others | 13G | 5.30%1.23M shares | New | Dec 15, 2025 | SEC |
| Jun 30, 202512:08 PM ET | BIOS Fund I, LPand 23 others | 13D/A | 49.80%10.3M shares | −2.60 ppfrom 52.40% | Jun 27, 2025 | SEC |
| May 27, 20254:15 PM ET | BIOS Fund I, LPand 23 others | 13D/A | 52.40%10.0M shares | – | May 22, 2025 | SEC |
| Aug 19, 2024 | BIOS Fund I, LP | 13DOld format | – | New | – | SEC |
Form 144: proposed insider sales
1 notice from officers, directors and other affiliates planning to sell Actuate Therapeutics, Inc. shares, newest first.
| Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|
| Dec 11, 20254:22 PM ET | Kairos Venture Partners II, L.P.Affiliate | 280.0K | $2.13M | Dec 11, 2025 | Jones Trading Institutional Services, LLC | SEC |